A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

June 20, 2022

Primary Completion Date

January 2, 2027

Study Completion Date

March 2, 2027

Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL

Telitacicept

Subcutaneous injection weekly for 52 weeks

BIOLOGICAL

Placebo

Subcutaneous injection weekly for 52 weeks

Trial Locations (78)

1012

Manila Site, Manila

1097

Budapest Site, Budapest

1229

Makati City Site, Makati City

1431

Sofia Site 1, Sofia

1463

Sofia Site 4, Sofia

Sofia Site 5, Sofia

1612

Sofia Site 3, Sofia

2605

Garran Site, Garran

4023

Plovdiv Site, Plovdiv

4030

Los Baños Site, Los Baños

4032

Debrecen Site, Debrecen

4217

Batangas Site, Batangas

5400

San Juan Site, San Juan

Sevlievo Site, Sevlievo

5700

Gyula Site, Gyula

5800

Pleven Site, Pleven

6000

Stara Zagora Site, Stara Zagora

6150

Murdoch Site, Murdoch

7002

Ruse Site, Rousse

9000

Cagayan de Oro City Site, Cagayan de Oro

20902

Wheaton, Maryland Site, Wheaton

33014

Miami, FL Site, Miami

33765

Tampa, Florida Site, Tampa

36207

Anniston, Alabama Site, Anniston

41010

Sevilla Site 1, Seville

41013

Sevilla Site 2, Seville

44670

Guadalajara Site, Guadalajara

46017

Valencia Site, Valencia

48149

Muenster Site, Münster

48439

Grand Blanc Site, Grand Blanc

50021

Medellin site 2, Medellín

50937

Koeln Site, Cologne

62448

Cuernavaca Site, Cuernavaca

67000

Mexico Site 2, México

72218

Quatre Bornes Site, Quatre Bornes

76034

Colleyville, Texas Site, Colleyville

76710

Waco Site, Waco

77084

Houston Site, Houston

77521

Baytown Site, Baytown

91345

Mission Hills Site, Mission Hills

91360

Thousands Oaks Site, Thousand Oaks

92868

Orange Site, Orange

230002

Monteria site, Montería

680003

Bucaramanga site, Bucaramanga

7500010

Santiago Site 4, Santiago

7500710

Santiago Site 1, Santiago

7501126

Santiago Site 3, Santiago

8330336

Santiago Site 2, Santiago

B1878DVB

Quilmes Site, Quilmes

S2000PBJ

Rosario Site, Rosario

T4000AXL

San Miguel de Tucuman Site 1, San Miguel de Tucumán

T4000ICL

San Miguel de Tucuman Site 2, San Miguel de Tucumán

C1046AAQ

Ciudad Autonoma Buenos Aires Site 2, Ciudad Autonoma Buenos Aires

X5000AVE

Cordoba Site, Córdoba

080002

Barranquilla site, Barranquilla

080020

Barranquilla site, Barranquilla

050025

Medellin Site 1, Medellín

Unknown

Guatemala site, Guatemala City

06700

Ciudad de Mexico Site, Mexico City

06760

Mexico site 1, México

85-065

Bydgoszcz Site, Bydgoszcz

85-168

Bydgoszcz Site 2, Bydgoszcz

85-605

Bydgoszcz Site 3, Bydgoszcz

41-902

Bytom Site, Bytom

40-748

Katowice Site, Katowice

31-501

Krakow Site 1, Krakow

90-368

Lodz Site, Lodz

82-200

Malbork Site, Malbork

60-681

Poznan Site 2, Poznan

61-113

Poznan SIte, Poznan

61-731

Poznań Site, Poznan

71-252

Szczecin Site, Szczecin

00-874

Warszawa Site 2, Warsaw

02-637

Warszawa Site 3, Warsaw

04-305

Warszawa Site, Warsaw

50-556

Wroclaw Site 2, Wroclaw

00725

Caguas Site, Caguas

00917

San Juan Site, San Juan

All Listed Sponsors
lead

RemeGen Co., Ltd.

INDUSTRY